BioSpace News Archive

Teva announced the appointment in a filing with the U.S. Securities and Exchange Commission. Zaks will serve on the board’s Science and Technology Committee.

Marion Gruber, director of the agency’s Office of Vaccines Research & Review is leaving at the end of October. Phil Krause, OVRR’s deputy director, is exiting in November.

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, and SENAI CIMATEC, an important education, research, and innovation institute, announced that they will co-develop HDT Bio’s RNA COVID-19 vaccine, HDT-301, in Brazil.

Eagle Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office has granted the Company U.S. Patent No. 11,103,483, entitled “Formulations of Bendamustine.” Eagle is submitting the ‘483 patent for listing in the U.S. Food and Drug Administration’s Orange Book for both BENDEKA® and BELRAPZO®.

Johnson & Johnson, together with a consortium of global partners, announced results from the primary analysis of a Phase 2b HIV vaccine clinical trial known as the Imbokodo study.

McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter from Health Canada to begin recruiting human subjects for a placebo-controlled trial using cannabis- oil for treatment of insomnia in major depressive disorder.

BeyondSpring today announced a late-breaking oral presentation at the European Society for Medical Oncology 2021 Congress taking place virtually September 16-21, 2021.

Alithea Genomics, a rapidly growing player in the transcriptomics field, has announced the launch of its first MERCURIUS BRB-seq kits, which enable high-throughput and cost-efficient RNA-seq library preparation from a wide range of RNA samples.

CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies.

Berkshire Biomedical, LLC announces today that it joins with the millions of advocates around the world in recognition of International Overdose Awareness Day.